Medical expenditures for colorectal cancer diagnosis and treatment: A 10-year high-level-hospital-based multicenter retrospective survey in China, 2002−2011

Jufang Shi; Guoxiang Liu; Hong Wang; Ayan Mao; Chengcheng Liu; Lanwei Guo; Huiyao Huang; Jiansong Ren; Xianzhen Liao; Yana Bai; Xiaojie Sun; Xinyu Zhu; Jialin Wang; Bingbing Song; Jinyi Zhou; Lin Zhu; Haike Lei; Yuqin Liu; Yunyong Liu; Lingbin Du; Yutong He; Kai Zhang; Li Ni; Wanqing Chen; Min Dai; Jie He

doi:10.21147/j.issn.1000-9604.2019.05.12

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

These conservative estimates illustrated that medical expenditures for CRC diagnosis and treatment in tertiary hospitals in China were substantial and increased rapidly over the 10 years, with drugs continually being the main expense by 2011. Relatively, medical expenditures are lower for CRC in the earlier stages. These findings will facilitate the economic evaluation of CRC prevention and control in China.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Shi et al. (2019) studied this question.

synapsesocial.com/papers/69dd38c421232b10ec40c3f3 https://doi.org/10.21147/j.issn.1000-9604.2019.05.12

View Full Paper

Ask AI

Bookmark

Share

Medical expenditures for colorectal cancer diagnosis and treatment: A 10-year high-level-hospital-based multicenter retrospective survey in China, 2002−2011

Ask about this paper

Abstract

Discussion

Cite This Study

Medical expenditures for colorectal cancer diagnosis and treatment: A 10-year high-level-hospital-based multicenter retrospective survey in China, 2002−2011

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading